D. Iain Dukes compensation by year
Traws Pharma Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $539,000 |
| Bonus | $237,375 |
| Stock awards | $86,077 |
| Option awards | $539,472 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $0 |
| Total | $1,401,924 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Traws Pharma, Inc. DEF 14A filed May 29, 2026, accession 0001104659-26-067945, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Traws Pharma, Inc. filed document, accession 0001104659-26-067945. Every figure is read from that document and cited to the page and table it appears in. Filed May 29, 2026.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed May 29, 2026)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-07-09 | Grant or award derivative | — | 274,000 | $0.00 | 274,000 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Traws Pharma’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| D. Iain Dukes · this page | Chief Executive Officer | $1,401,924 |
| Charles Pauza | Chief Science Officer | $1,014,040 |
| Nikolay Savchuk | Chief Operating Officer | $734,810 |
| Werner Cautreels | Former Chief Executive Officer | $353,897 |
The full Traws Pharma compensation record
free company briefThis page is one person within Traws Pharma's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Traws Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.